主持国家自然科学基金1项，省市级科研课题8项，担任2025国家重大专项子课题分中心负责人，以第一作者或者通讯作者发表论文40余篇，SCI发表近20篇，参编皮肤病论著10余部，拥有国家发明专利1项，实用新型4项，担任《世界临床药物》、《上海医药》等杂志的审稿专家。
Dr. Jiang received series of financial supports from the National Natural Science Foundation of China, and provincial or municipal-level scientific research projects. He has published more than 40 papers as the first or corresponding author, including nearly 20 SCI papers, and co-authored more than 10 dermatological books. He holds 1 national patent and 4 utility model patents. He serves as a peer reviewer for many academic journals, such as World Clinical Drugs and Shanghai Medical & Pharmaceutical Journal.
1. Zhao R, Zhang C, Tang C, Wu X, Hu S, Luo Q, Jia N, Fan L, Wang Y, Jiang W, Chen Q. Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo. J Ethnopharmacol. 2025 Jan 10;336:118706. doi: 10.1016/j.jep.2024.118706. (IF: 5.4)
2. Shen F, Song Y, Qiang Y, Gao X, Li S, Zhang R, Gao Z, Li B, Jiang W, Wang R. Tobacco Smoking Interacted with Alcohol Drinking Could Increase the Failure of PASI75 Achievement at Week 8 Among Patients with Psoriasis: Findings Based on a Psoriasis Cohort. Psoriasis (Auckl). 2024 Sep 23;14:103-114. doi: 10.2147/PTT.S484609. (IF: 2.9)
3. Wu X, Hu S, Jia N, Zhang C, Liu C, Song J, Kuai L, Jiang W, Li B, Chen Q. Accurate network pharmacology and novel ingredients formula of herbal targeting estrogen signaling for psoriasis intervention. J Ethnopharmacol. 2024 Jul 15;329:118099. doi: 10.1016/j.jep.2024.118099. (IF: 5.4)
4. Wang XM, Liu YQ, Li B, Li M, Peng Y, Jiang WC. Single-system Langerhans Cell Histiocytosis with Skin Ulcers as the Initial Presentation. Acta Derm Venereol. 2024 Aug 5;104:adv40193. doi: 10.2340/actadv.v104.40193. (IF: 3.6)
5. Fan L, Shen F, Wu D, Ren T, Jiang W. KGRT peptide incorporated hydrogel with antibacterial activity for wound healing by optimizing cellular functions via ERK/eNOS signaling. Int J Biol Macromol. 2024 Apr;265(Pt 1):130781. doi: 10.1016/j.ijbiomac.2024.130781. (IF: 8.2)
6. Hu S, Shen F, Jia N, Zhang C, Wu X, Jiang W, Li B, Chen Q. Novel monomers recipe derived from Shengji-Huayu formula targeting PI3K/Akt signaling pathway for diabetic wound healing based on accurate network pharmacology. J Ethnopharmacol. 2025 Mar 26;344:119509. doi: 10.1016/j.jep.2025.119509. (IF: 4.8)
7. Wu X, Liu C, Zhang C, Kuai L, Hu S, Jia N, Song J, Jiang W, Chen Q, Li B. The Role of Lactate and Lactylation in the Dysregulation of Immune Responses in Psoriasis. Clin Rev Allergy Immunol. 2025 Mar 13;68(1):28. doi: 10.1007/s12016-025-09037-2. (IF: 8.4)
8. .Luo B, Ding X, Hu Y, Tian M, Wu J, Shi H, Lu X, Xia X, Guan W, Jiang W. Shikonin hastens diabetic wound healing by inhibiting M1 macrophage polarisation through the MAPK signaling pathway. Mol Immunol. 2025 Jan;177:73-84. doi: 10.1016/j.molimm.2024.12.002. (IF: 3.2)
9. Wang G, Hu S, Shen F, Wang Q, Ye B, Wang X, Zhang C, Jia N, Li B, Chen Q, Jiang W. Sheng-ji Hua-yu Formula promotes diabetic ulcer healing via regulating the cAMP/PKA/CREB signaling pathway. J Ethnopharmacol. 2025 Jul 24;351:120105. doi: 10.1016/j.jep.2025.120105. (IF: 5.4)
10. Wang X, Shi H, Tang S, Yang Y, Zheng Q, Jiang W. Comparative Case Series of Herpes Zoster in Older Immunocompromised Chinese Adults: Clinical, Immunological, and Treatment Profiles in Four Cases Over 60. Infect Drug Resist. 2025 Aug 31;18:4513-4525. doi: 10.2147/IDR.S531066. (IF: 2.9)
